Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 15 Breast Neoplasms 14 Sarcoma 11 Squamous Cell Carcinoma of Head and Neck 10 Glioblastoma 10 Esophageal Neoplasms 9 Rectal Neoplasms 8 Stomach Neoplasms 7 Urinary Bladder Neoplasms 6 Neoplasms 6 Carcinoma, Hepatocellular 6 Pancreatic Neoplasms 5 Colorectal Neoplasms 5 Brain Neoplasms 5 Oropharyngeal Neoplasms 4 Lung Neoplasms 4 Hypopharyngeal Neoplasms 4 Head and Neck Neoplasms 4 Glioma 4 Colonic Neoplasms 4 Recurrence 3 Prostatic Neoplasms 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Neoplasm Metastasis 3 Mouth Neoplasms 3 Melanoma 3 Astrocytoma 3 Triple Negative Breast Neoplasms 2 Thyroid Neoplasms 2 Skin Neoplasms 2

Interventions

Radiotherapy 4 osimertinib 3 aflutinib 3 Radiosurgery 3 Pemetrexed 3 Drug Therapy 3 Carboplatin 3 toripalimab 2 pembrolizumab 2 Docetaxel 2 tislelizumab 1 sugemalimab 1 lenvatinib 1 cemiplimab 1 brigatinib 1 Vinorelbine 1 Tyrosine Kinase Inhibitors 1 Surgical Procedures, Operative 1 S 1 (combination) 1 Platinum Compounds 1 Platinum 1 Pharmaceutical Preparations 1 Paclitaxel 1 Neoadjuvant Therapy 1 JDQ443 1 Immune Checkpoint Inhibitors 1 HM781-36B 1 Gemcitabine 1 Diphenhydramine 1 Cryotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

NSCLC × Surgical Procedures, Operative × 1 year × Clear all

NCT07089199 2025-07-28

TitAN

Qilu Hospital of Shandong University

Phase 2 Not yet recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡